2024-10-23T09:50:16-05:00 2023-12-31 946214841 ARMANINO LLP 1520 S FIFTH STREET SUITE 309 ST CHARLES MO 63303 990 2023-01-01 272233336 PEDAL THE CAUSE PEDA 3147871990 9288 DIELMAN INDUSTRIAL DRIVE ST LOUIS MO 63132 DAVID DRIER EXECUTIVE DIRECTOR 3147871990 2024-10-23 1 0 JENNIFER M VACHA P01251998 6362553000 2024-10-23 2023 2024-10-15 13:58:12Z DAVID DRIER 9288 DIELMAN INDUSTRIAL DRIVE ST LOUIS MO 63132 7293373 0 X WWW.PEDALTHECAUSE.ORG X 2010 MO TO CONDUCT AN ANNUAL FUNDRAISING BIKE CHALLENGE TO RAISE AWARENESS AND FUNDS FOR CANCER RESEARCH. 29 29 9 750 0 0 6030969 6695334 334480 406030 20685 40528 -40796 -39733 6345338 7102159 4543878 5003916 0 0 844391 927586 0 0 627432 1271782 1370109 6660051 7301611 -314713 -199452 1636567 1476656 199168 238709 1437399 1237947 X OUR MISSION IS TO PROVIDE FUNDING FOR CANCER RESEARCH AT SITEMAN CANCER CENTER AND SITEMAN KIDS AT ST. LOUIS CHILDREN'S HOSPITAL THROUGH OUR ANNUAL CYCLING CHALLENGE. IT IS OUR HOPE THAT RESEARCH FUNDED BY PEDAL THE CAUSE WILL ULTIMATELY LEAD TO A CURE FOR CANCER. 0 0 6357078 5003916 423828 IN 2023, OVER 3,200 ADULTS AND CHILDREN PARTICIPATED IN PEDAL THE CAUSE, SUPPORTED BY 700 VOLUNTEERS, WHO TOGETHER RAISED OVER $5.0 MILLION TO FUND CANCER RESEARCH. OVER THE PAST 14 YEARS, PEDAL THE CAUSE HAS CUMULATIVELY DONATED $45.8 MILLION - SUPPORTING 219 ADULT AND PEDIATRIC CANCER RESEARCH PROJECTS. MAJOR BREAKTHROUGHS MADE POSSIBLE BY PEDAL THE CAUSE FUNDS INCLUDE THE DEVELOPMENT OF DNA AND PEPTIDE VACCINES FOR MULTIPLE CANCER TYPES, CANCER GOGGLES TO HELP SURGEONS SEE CANCER CELLS, IMMUNOTHERAPY HARNESSING OUR BODY'S 'NATURAL KILLER' CELLS AND CUTTING-EDGE RESEARCH IN THE UNDERSTANDING OF CANCER STEM-CELLS.(SEE SCHEDULE O)PEDAL THE CAUSE FUNDS HAVE BEEN INSTRUMENTAL IN OBTAINING SPORE (SPECIALIZED PROGRAMS OF RESEARCH EXCELLENCE) GRANTS IN LEUKEMIA AND PANCREATIC CANCER, WHICH LEAD A NATIONAL GROUP OF EXPERTS IN COLLABORATIVE RESEARCH. PEDAL THE CAUSE FUNDED CLINICAL TRIALS ARE A KEY COMPONENT OF THE ROBUST CLINICAL TRIAL PROGRAM AT SITEMAN CANCER CENTER, WHICH RANKS AS THE LARGEST CANCER CLINICAL TRIALS PROGRAM IN THE MIDWEST AND THIRD LARGEST IN THE COUNTRY.FOR EVERY $1 PEDAL THE CAUSE DONATES TO CANCER RESEARCH, RESEARCHERS HAVE SUCCESSFULLY ATTRACTED SIGNIFICANT ADDITIONAL EXTERNAL FUNDING TO FURTHER THEIR RESEARCH, AVERAGING $13 FOR EVERY $1 INITIAL AWARD.SIGNIFICANT 2023 EXTERNAL FUNDING INCLUDED: -$2.8M AWARD FROM THE NATIONAL INSTITUTE OF HEALTH FOR ADVANCING A NEW IMAGING TECHNOLOGY THAT MAY REDUCE SURGERIES REQUIRED FOR RECTAL CANCER PATIENTS FROM A 2020 PEDAL THE CAUSE GRANT.-$10.9M NATIONAL CANCER INSTITUTE 5-YEAR SPORE GRANT FOR CLINICAL TRAILS AIMED AT IMPROVING THERAPIES FOR PANCREATIC DUCTAL ADENOCARCINOMA FROM ALL STEMMING FROM A PEDAL THE CAUSE GRANT. 6357078 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 17 0 1 9 1 0 0 0 0 0 0 0 0 0 0 0 0 X 29 29 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 X X ANGIE PINON 3147871990 9288 DIELMAN INDUSTRIAL DRIVE ST LOUIS MO 63132 WILLIAM TIMMONS PRESIDENT 2.00 X X 0 0 0 DAVID MOONS VICE PRESIDENT 2.00 X X 0 0 0 RENEE VAN HORN SECRETARY 2.00 X X 0 0 0 DAVID YONCE TREASURER 2.00 X X 0 0 0 BRIAN ASHWORTH IMMEDIATE PAST PRESIDENT 2.00 X X 0 0 0 ED ALIZADEH DIRECTOR 1.00 X 0 0 0 JOE BERGER DIRECTOR 1.00 X 0 0 0 EMILY CALLAHAN DIRECTOR 1.00 X 0 0 0 RYAN FIELDS DIRECTOR 1.00 X 0 0 0 BART FRENCH DIRECTOR 1.00 X 0 0 0 DAIN GIESIE DIRECTOR 1.00 X 0 0 0 JUDY GLIK DIRECTOR 1.00 X 0 0 0 BILL GREUBEL DIRECTOR (THRU 12/23) 1.00 X 0 0 0 TERI GRIEGE DIRECTOR 1.00 X 0 0 0 DEBBIE HANKIN DIRECTOR 1.00 X 0 0 0 BILL LINDE DIRECTOR 1.00 X 0 0 0 DOUG MANGERS DIRECTOR 1.00 X 0 0 0 MARK MANNING DIRECTOR 1.00 X 0 0 0 JEAN MCDONALD DIRECTOR 1.00 X 0 0 0 MELISSA MERLIN DIRECTOR 1.00 X 0 0 0 PETER MITCHELL DIRECTOR (THRU 8/23) 1.00 X 0 0 0 RICK MOECKEL DIRECTOR 1.00 X 0 0 0 NICK OVERKAMP DIRECTOR 1.00 X 0 0 0 JAQUI ROGERS DIRECTOR 1.00 X 0 0 0 MICHAEL SCHWARTZ DIRECTOR 1.00 X 0 0 0 EMERY SKOLFIELD DIRECTOR 1.00 X 0 0 0 SHANE SPEARS DIRECTOR 1.00 X 0 0 0 JIM STARR DIRECTOR (THRU 12/23) 1.00 X 0 0 0 NICOLE STUBBLEFIELD DIRECTOR 1.00 X 0 0 0 BRAD VERDIGETS DIRECTOR 1.00 X 0 0 0 THEODORE WHEELER DIRECTOR 1.00 X 0 0 0 PETE WYATT DIRECTOR 1.00 X 0 0 0 DAVID DRIER EXECUTIVE DIRECTOR 40.00 X 237426 0 16079 ASHLEY SAITTA DIRECTOR OF OPERATIONS & COMMUNITY EVENTS 40.00 X 137652 0 3522 PAM MANDELKER DIRECTOR OF DEVELOPMENT 32.00 X 126294 0 7611 ELEANOR GOEDEKE DIRECTOR OF COMMUNICATIONS & MARKETING 40.00 X 108122 0 13327 609494 0 40539 4 0 1 0 BIG SHARK 1155 BIG BEND SAINT LOUIS MO 63117 COURSE MANAGEMENT 159050 1 64233 6631101 163069 6695334 RIDER REGISTRATION FEE 900099 406030 406030 406030 40528 40528 98835 98835 0 0 6702 64233 64233 -57531 -57531 45944 28146 17798 17798 7102159 423828 0 -17003 5003916 5003916 253505 86302 167203 546995 423589 68210 55196 9241 6610 1305 1326 57184 37942 8897 10345 60661 32757 11525 16379 524 524 81670 81670 1825 1825 138409 138409 44105 8380 35725 44619 8478 36141 45745 8692 37053 13014 13014 16354 3107 13247 28186 28186 EVENT AND DEVELOPMENT 955658 852264 103394 7301611 6357078 317101 627432 200 500 772948 798632 611714 424608 68580 79180 15060 18283 81381 44072 24273 37309 143792 118144 1636567 1476656 54348 118821 144820 119888 199168 238709 X 753100 728713 684299 509234 1437399 1237947 1636567 1476656 -199452 0 X 0 1 X 1 0 X 6093073 5392046 5604297 6030969 6695334 29815719 6093073 5392046 5604297 6030969 6695334 29815719 1088256 28727463 20685 40528 61213 29876932 1911124 0.96150 0.95580 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 81381 44072 37309 37309 RIGHT-OF-USE ASSET 118144 118144 OPERATING LEASE LIABILITY 119888 119888 X 7323013 128475 92379 220854 7102159 0 7102159 7522465 128475 92379 220854 7301611 0 7301611 PART X, LINE 2: THE ORGANIZATION QUALIFIES AS A NONPROFIT ORGANIZATION AND IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THE ORGANIZATION HAS ADDRESSED THE PROVISIONS OF ASC 740, ACCOUNTING FOR INCOME TAXES. IN THAT REGARD, THE ORGANIZATION HAS EVALUATED ITS TAX POSITIONS, EXPIRING STATUTES OF LIMITATIONS, AUDITS, PROPOSED SETTLEMENTS, CHANGES IN TAX LAW, AND NEW AUTHORITATIVE RULINGS AND BELIEVES THAT NO PROVISION FOR INCOME TAXES IS NECESSARY, AT THIS TIME, TO COVER ANY UNCERTAIN TAX POSITIONS. PART XI, LINE 2D - OTHER ADJUSTMENTS: RECLASS OF COST OF GOODS SOLD AGAINST INCOME 28,146. RECLASS OF DIRECT FUNDRAISING EXPENSES AGAINST INCOME 64,233. PART XII, LINE 2D - OTHER ADJUSTMENTS: RECLASS OF COST OF GOODS SOLD AGAINST INCOME 28,146. RECLASS OF DIRECT FUNDRAISING EXPENSES AGAINST INCOME 64,233. PTC WEEKEND 70935 64233 6702 64233 70935 64233 6702 64233 64233 -57531 1 SITEMAN KIDS AT STL CHILDREN'S HOSPITAL (STL CHILDREN'S HOSP FOUND) 1001 HIGHLANDS PLAZA DR WEST 160 ST LOUIS MO 631101337 431626863 501(C)(3) 1501175 0 SUPPORT CANCER RESEARCH SITEMAN CANCER CENTER (FOUNDATION FOR BARNES JEWISH HOSP) 1001 HIGHLANDS PLAZA DR WEST 140 ST LOUIS MO 631101337 431648435 501(C)(3) 3502741 0 SUPPORT CANCER RESEARCH 2 0 PART I, LINE 2: PEDAL THE CAUSE (PTC) MAINTAINS RECORDS TO SUBSTANTIATE THE AMOUNT OF ASSISTANCE AWARDED. PTC PROVIDES FUNDING TO SITEMAN CANCER CENTER (THROUGH BARNES JEWISH HOSPITAL FOUNDATION) AND SITEMAN KIDS AT ST. LOUIS CHILDREN'S HOSPITAL (THROUGH THE ST. LOUIS CHILDREN'S HOSPITAL FOUNDATION). BOTH ORGANIZATIONS CONDUCT CANCER RESEARCH AND ARE RECOGNIZED AS TAX-EXEMPT ORGANIZATIONS UNDER INTERNAL REVENUE CODE SECTION 501(C)(3). PTC DOES NOT PRESENTLY FUND CANCER RESEARCH BY OTHER ORGANIZATIONS. X X 0 0 0 0 0 0 0 0 0 DAVID DRIER EXECUTIVE DIRECTOR 197426 0 40000 0 0 0 3000 0 13079 0 253505 0 0 0 X 13 98835 PUBLICLY TRADED EXCHANGE X EVENT MEALS 12 64233 COMPARABLE SALES 0 0 1 0 PART I, COLUMN (B): THIS NUMBER REPRESENTS THE NUMBER OF CONTRIBUTIONS, NOT THE NUMBER OF ITEMS CONTRIBUTED. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS INITIALLY PREPARED BY THE OUTSIDE ACCOUNTING FIRM. A DRAFT COPY OF THE RETURN IS PROVIDED TO MANAGEMENT FOR REVIEW. CHANGES, IF ANY, ARE DISCUSSED AND A FINAL COPY OF FORM 990 IS PRESENTED TO THE FINANCE COMMITTEE FOR REVIEW. UPON REVIEW BY THE FINANCE COMMITTEE, A COPY OF FORM 990 IS MADE AVAILABLE TO THE BOARD OF DIRECTORS FOR APPROVAL PRIOR TO FILING WITH IRS. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY APPLIES TO ALL DIRECTORS AND OFFICERS OF PEDAL THE CAUSE, AND ANY OTHER PERSON WHO IS IN A POSITION TO EXERCISE SUBSTANTIAL INFLUENCE OVER THE DECISIONS AND AFFAIRS OF THE CORPORATION. EACH COVERED PERSON WILL ANNUALLY SIGN A STATEMENT THAT AFFIRMS SUCH PERSON 1) HAS RECEIVED A COPY OF THE POLICY; 2) HAS READ AND UNDERSTANDS THE POLICY; 3) HAS AGREED TO COMPLY WITH THE POLICY; AND 4) UNDERSTANDS THAT THE CORPORATION IS EXEMPT FROM FEDERAL INCOME TAX AND TO MAINTAIN ITS FEDERAL TAX EXEMPTION THE CORPORATION MUST ENGAGE PRIMARILY IN ACTIVITIES THAT ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. TO ENSURE THAT THE CORPORATION OPERATES IN A MANNER CONSISTENT WITH ITS TAX-EXEMPT PURPOSES AND THAT IT DOES NOT ENGAGE IN ACTIVITIES THAT COULD JEOPARDIZE ITS STATUS AS AN ORGANIZATION EXEMPT FROM FEDERAL INCOME TAX, THE BOARD WILL CONDUCT PERIODIC REVIEWS. THE PERIODIC REVIEWS WILL, AT A MINIMUM, INCLUDE THE FOLLOWING SUBJECTS: 1) WHETHER THE CORPORATION'S COMPENSATION ARRANGEMENTS ARE REASONABLE, BASED ON COMPETENT SURVEY INFORMATION, AND ARE THE RESULT OF ARM'S- LENGTH BARGAINING; 2) WHETHER TRANSACTION AND ARRANGEMENTS WITH OTHER ENTITIES AND INDIVIDUALS CONFORM TO THE CORPORATION'S POLICIES, ARE PROPERLY RECORDED, REFLECT REASONABLE PAYMENTS FOR GOODS AND SERVICES, FURTHER THE CORPORATION'S TAX-EXEMPT PURPOSES AND DO NOT RESULT IN PRIVATE INUREMENT, IMPERMISSIBLE PRIVATE BENEFIT, OR IN AN EXCESS BENEFIT TRANSACTION. WHEN CONDUCTING REVIEWS, THE BOARD SHOULD RELY ON APPROPRIATE OUTSIDE EXPERTS (ATTORNEYS, APPRAISERS, OR COMPENSATION OR OTHER CONSULTANTS). FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION OF THE EXECUTIVE DIRECTOR IS APPROVED BY THE EXECUTIVE COMMITTEE. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION ADDRESSES REQUESTS TO VIEW GOVERNING DOCUMENTS, THE CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ON A CASE BY CASE BASIS.